Primary Myelofibrosis Terminated Phase 2 Trials for Ruxolitinib (DB08877)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

DBCOND0001581 (Primary Myelofibrosis)Terminated2 IdentifierTitlePurposeDrugs
NCT01790295Ruxolitinib Prior to Transplant in Patients With MyelofibrosisTreatment
NCT02091752A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)Treatment